Diagnosis of the antiphospholipid syndrome: how far to go?
The past decade has seen an evolution in the way that thrombophilic conditions are diagnosed and understood. This has largely evolved through the detection of single nucleotide polymorphisms in critical regulating proteins that are thought to confer significant structural-functional changes at key points in the coagulation cascade. The antiphospholipid syndrome (APS) is a complex hypercoagulable disorder that as yet defies the possibility of simple, predictive testing.
Merrill
Joan T
JT
Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, 825 Northeast 13th St., Oklahoma City, OK 73104, USA. joan-merrill@omrf.ouhsc.edu
D017152:Antibodies, Antiphospholipid / Q000032:analysis; D016736:Antiphospholipid Syndrome / Q000175:diagnosis* / Q000503:physiopathology; D006801:Humans; D010641:Phenotype; D012720:Severity of Illness Index
D017152:Antibodies, Antiphospholipid